This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Illumina Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Dorry Poa: Innovator in Sequencing Reagents
Introduction
Dorry Poa is a notable inventor based in Singapore, recognized for his contributions to the field of sequencing reagents. With a focus on innovative compositions and methods, he has made significant strides in enhancing the efficiency of sequencing technologies.
Latest Patents
Dorry Poa holds 1 patent for his invention titled "Compositions, methods, kits, cartridges, and systems for sequencing reagents." This patent describes a composition that includes one or more modified nucleotides, featuring a purine or pyrimidine base and a sugar moiety with a 3'-hydroxy blocking group, along with a radical scavenger. The composition is lyophilized for stability. Additionally, the patent outlines methods for rehydration of the compositions and includes kits and cartridges designed for effective reagent storage and application.
Career Highlights
Dorry Poa is currently employed at Illumina Corporation, a leading company in the field of genomics and sequencing technologies. His work at Illumina has allowed him to contribute to groundbreaking advancements in the life sciences sector.
Collaborations
Throughout his career, Dorry has collaborated with esteemed colleagues, including Oliver Jon Miller and Youna Ro. These partnerships have fostered a collaborative environment that encourages innovation and the development of new technologies.
Conclusion
Dorry Poa's work in sequencing reagents exemplifies the impact of innovative thinking in the field of genomics. His contributions continue to shape the future of sequencing technologies, making significant advancements in the industry.